Anti-breast cancer potential of a new xanthine derivative: In silico, antiproliferative, selectivity, VEGFR-2 inhibition, apoptosis induction and migration inhibition studies

International, W. Breast Cancer Statistics. 2023. 〈https://www.wcrf.org/cancer-trends/breast-cancer-statistics〉.(Accessed 30 March 2023). Pillaiyar, 2020, A medicinal chemistry perspective of drug repositioning: Recent advances and challenges in drug discovery, Eur. J. Med Chem., 195, 10.1016/j.ejmech.2020.112275 Hu, 2022, The research progress of antiangiogenic therapy, immune therapy and tumor microenvironment, Front. Immunol., 13 Lugano, 2020, Tumor angiogenesis: causes, consequences, challenges and opportunities, Cell Mol. Life Sci., 77, 1745, 10.1007/s00018-019-03351-7 Tripathi, 2020, Recent updates on the resistance mechanisms to epidermal growth factor receptor tyrosine kinase inhibitors and resistance reversion strategies in lung cancer, Med Res Rev., 40, 2132, 10.1002/med.21700 Nicholson, 2001, EGFR and cancer prognosis, Eur. J. Cancer, 37, S9, 10.1016/S0959-8049(01)00231-3 Ayati, 2020, A review on progression of epidermal growth factor receptor (EGFR) inhibitors as an efficient approach in cancer targeted therapy, Bioorg. Chem., 99, 10.1016/j.bioorg.2020.103811 Itatani, 2018, Resistance to anti-angiogenic therapy in cancer-alterations to Anti-VEGF pathway, Int. J. Mol. Sci., 19, 10.3390/ijms19041232 Zhu, 2017, New knowledge of the mechanisms of sorafenib resistance in liver cancer, Acta Pharmacol. Sin., 38, 614, 10.1038/aps.2017.5 Yokoyama, 2017, Activation of ERK1/2 causes pazopanib resistance via downregulation of DUSP6 in synovial sarcoma cells, Sci. Rep., 7, 45332, 10.1038/srep45332 Feng, 2023, Editorial: Exploring the therapeutic effects of synthetic, semi-synthetic and naturally derived compounds against cancer, Front. Pharmacol., 14, 1251835, 10.3389/fphar.2023.1251835 Becker, 2010, Side-effects of long-term administration of erlotinib in patients with non-small cell lung cancer, J. Thorac. Oncol., 5, 1477, 10.1097/JTO.0b013e3181e981d9 Galimont-Collen, 2007, Classification and management of skin, hair, nail and mucosal side-effects of epidermal growth factor receptor (EGFR) inhibitors, Eur. J. Cancer, 43, 845, 10.1016/j.ejca.2006.11.016 Metwaly, 2019, Black ginseng and its saponins: preparation, phytochemistry and pharmacological effects, 24, 1856 Metwaly, 2021, Traditional ancient Egyptian medicine: a review, 28, 5823 Cova, 2019, Exploring cocoa properties: is theobromine a cognitive modulator?, Psychopharmacology, 236, 561, 10.1007/s00213-019-5172-0 Fredholm, 2011, Theobromine and the pharmacology of cocoa, Methylxanthines, 201 Perez-Perez, 2019, Methylxanthines: potential therapeutic agents for glioblastoma, Pharmaceuticals, 12, 130, 10.3390/ph12030130 Sugimoto, 2014, Nutr. Cancer, 66, 419, 10.1080/01635581.2013.877497 Shojaei-Zarghani, 2020, Effectiveness of theobromine on inhibition of 1, 2-dimethylhydrazine-induced rat colon cancer by suppression of the Akt/GSK3β/β-catenin signaling pathway, J. Funct. Foods, 75, 10.1016/j.jff.2020.104293 Nomiri, 2022, Exploiting systems biology to investigate the gene modules and drugs in ovarian cancer: A hypothesis based on the weighted gene co-expression network analysis, Biomed. Pharmacother., 146, 10.1016/j.biopha.2021.112537 Barcz, 1998, The influence of theobromine on angiogenic activity and proangiogenic cytokines production of human ovarian cancer cells, Oncol. Rep., 5, 517 Elkaeed, E.B., et al., Discovery of New VEGFR-2 Inhibitors: Design, Synthesis, Anti-Proliferative Evaluation, Docking, and MD Simulation Studies. 2022. 27(19): p. 6203. Elkaeed, E.B., et al., In Silico, in Vitro VEGFR-2 Inhibition, and Anticancer Activity of A 3-(hydrazonomethyl) Naphthalene-2-ol Derivative. 2022, 1–16. Eissa, 2023, Design, semi-synthesis, anti-cancer assessment, docking, MD simulation, and DFT studies of novel theobromine-based derivatives as VEGFR-2 inhibitors and apoptosis inducers, Comput. Biol. Chem., 107, 10.1016/j.compbiolchem.2023.107953 Mahdy, 2023, New theobromine derivatives inhibiting VEGFR-2: design, synthesis, antiproliferative, docking and molecular dynamics simulations, Future Med. Chem., 15, 1233, 10.4155/fmc-2023-0089 Eissa, 2023, Identification of new theobromine-based derivatives as potent VEGFR-2 inhibitors: design, semi-synthesis, biological evaluation, and in silico studies, RSC Adv., 13, 23285, 10.1039/D3RA04007K Taghour, 2022, Design and synthesis of thiazolidine-2, 4-diones hybrids with 1, 2-dihydroquinolones and 2-oxindoles as potential VEGFR-2 inhibitors: in-vitro anticancer evaluation and in-silico studies, 37, 1903 Taghour, 2022, Design, synthesis, anti-proliferative evaluation, docking, and MD simulations studies of new thiazolidine-2, 4-diones targeting VEGFR-2 and apoptosis pathway, 17 Yousef, 2022, E)-N-(3-(1-(2-(4-(2, 2, 2-Trifluoroacetamido) benzoyl) hydrazono) ethyl) phenyl) nicotinamide: a novel pyridine derivative for inhibiting vascular endothelial growth factor receptor-2: synthesis, computational, and anticancer studies, 27, 7719 Elkaeed, 2022, The assessment of anticancer and VEGFR-2 inhibitory activities of a new 1H-indole derivative: in silico and in vitro approaches, 10, 1391 Taghour, M.S., et al., Discovery of New Quinoline and Isatine Derivatives as Potential VEGFR-2 Inhibitors: Design, Synthesis, Antiproliferative, Docking and MD Simulation Studies. 2022: 1–16. Suleimen, 2022, Isolation and in silico SARS-CoV-2 main protease inhibition potential of jusan coumarin, a new dicoumarin from Artemisia glauca, Molecules, 27, 2281, 10.3390/molecules27072281 Barcz, 2000, Adenosine receptor antagonism causes inhibition of angiogenic activity of human ovarian cancer cells, Oncol. Rep., 7, 1285 Kakuyamanee Iwazaki, 2001, Effect of methylxanthine derivatives on doxorubicin transport and antitumor activity., Curr. Drug Metab., 2, 379, 10.2174/1389200013338270 Sultani, 2017, Inhibitory effects of new mercapto xanthine derivatives in human mcf7 and k562 cancer cell lines, J. Heterocycl. Chem., 54, 450, 10.1002/jhet.2602 Carla Cadoná, 2016, Guaraná a caffeine-rich food increases oxaliplatin sensitivity of colorectal HT-29 cells by apoptosis pathway modulation, 16, 1055 Barcz, 1998, The influence of theobromine on angiogenic activity and proangiogenic cytokines production of human ovarian cancer cells, Oncol. Rep., 5, 517 Gil, 1993, Effect of purinergic receptor antagonists suramin and theobromine on tumor-induced angiogenesis in BALB/c mice, Folia Biol., 39, 63 Lee, 2010, Pharmacophore modeling and virtual screening studies for new VEGFR-2 kinase inhibitors, Eur. J. Med. Chem., 45, 5420, 10.1016/j.ejmech.2010.09.002 Machado, 2015, Synthesis, antiangiogenesis evaluation and molecular docking studies of 1-aryl-3-[(thieno [3, 2-b] pyridin-7-ylthio) phenyl] ureas: Discovery of a new substitution pattern for type II VEGFR-2 Tyr kinase inhibitors, Bioorg. Med. Chem., 23, 6497, 10.1016/j.bmc.2015.08.010 Wang, 2013, Dietary compound isoliquiritigenin inhibits breast cancer neoangiogenesis via VEGF/VEGFR-2 signaling pathway, PLoS One, 8 Dietrich, 2010, The design, synthesis, and evaluation of 8 hybrid DFG-out allosteric kinase inhibitors: a structural analysis of the binding interactions of Gleevec®, Nexavar®, and BIRB-796, Bioorg. Med. Chem., 18, 5738, 10.1016/j.bmc.2010.05.063 Xie, 2009, Pharmacophore modeling studies of type I and type II kinase inhibitors of Tie2, J. Mol. Graph. Model., 27, 751, 10.1016/j.jmgm.2008.11.008 Eskander, 2014, Incorporation of anti-angiogenesis therapy in the management of advanced ovarian carcinoma—mechanistics, review of phase III randomized clinical trials, and regulatory implications, Gynecol. Oncol., 132, 496, 10.1016/j.ygyno.2013.11.029 Biovia, D.S., Discovery studio modeling environment, 2017, Release. Elkaeed, 2023, Computer-assisted drug discovery of potential natural inhibitors of the SARS-CoV-2 RNA-dependent RNA polymerase through a multi-phase in silico approach, Antivir. Ther., 28, 10.1177/13596535231199838 Eissa, 2023, New theobromine derivative as apoptotic anti-triple-negative breast cancer targeting EGFR protein: CADD story, J. Mol. Struct., 1294, 10.1016/j.molstruc.2023.136336 Husein, D.Z., R. Hassanien, and M.J.R..a. Khamis, Cadmium Oxide Nanoparticles/graphene Composite: Synthesis, theoretical insights into reactivity and adsorption study. 2021. 11(43):, 27027–27041. Suleimen, Y.M., et al., Isolation and in silico inhibitory potential against SARS-CoV-2 RNA polymerase of the rare kaempferol 3-O-(6 ″-O-acetyl)-glucoside from Calligonum tetrapterum. 2022. 11(15), 2072. Abraham, M.J., et al., GROMACS: High Performance Molecular Simulations through Multi-level Parallelism from Laptops to Supercomputers. 2015. 1, 19–25. Brooks, B.R., et al., CHARMM: the Biomolecular Simulation Program. 2009. 30(10), 1545–1614. Jo, S., et al., CHARMM-GUI PDB Manipulator for Advanced Modeling and Simulations of Proteins Containing Nonstandard Residues. 2014. 96:, 235–265. Tuccinardi, T.J.Eoodd, What is thE Current Value of MM/PBSA and MM/GBSA Methods in Drug Discovery? 2021. 16(11), 1233–1237. Valdés-Tresanco, 2021, gmx_MMPBSA: a new tool to perform end-state free energy calculations with GROMACS, 17, 6281 Salentin, 2015, PLIP: fully automated protein–ligand interaction profiler, 43, W443 Amadei, 1993, Essential dynamics of proteins, 17, 412 Papaleo, E., et al., Free-energy Landscape, Principal Component Analysis, and Structural Clustering to Identify Representative Conformations from Molecular Dynamics Simulations: the Myoglobin Case, 2009. 27(8), 889–899. Wlodkowic, D., et al., Flow Cytometry-based Apoptosis Detection, 2009,. 19–32. Rodriguez, L.G., et al., Wound-healing assay. 2005, 23–29. Lipinski, 1997, Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings, Adv. Drug Deliv. Rev., 23, 3, 10.1016/S0169-409X(96)00423-1 Chuang, 2020, Learning molecular representations for medicinal chemistry: miniperspective, J. Med. Chem., 63, 8705, 10.1021/acs.jmedchem.0c00385 Ferreira, 2019, ADMET modeling approaches in drug discovery, Drug Discov. Today, 24, 1157, 10.1016/j.drudis.2019.03.015 Lipinski, 2004, Lead- and drug-like compounds: the rule-of-five revolution, Drug Discov. Today Technol., 1, 337, 10.1016/j.ddtec.2004.11.007 Veber, 2002, Molecular properties that influence the oral bioavailability of drug candidates, J. Med Chem., 45, 2615, 10.1021/jm020017n Idakwo, 2018, A review on machine learning methods for in silico toxicity prediction, J. Environ. Sci. Health C. Environ. Carcinog. Ecotoxicol. Rev., 36, 169, 10.1080/10590501.2018.1537118 Kruhlak, 2012, (Q)SAR modeling and safety assessment in regulatory review, Clin. Pharmacol. Ther., 91, 529, 10.1038/clpt.2011.300 Tice, 2021, In silico approaches in carcinogenicity hazard assessment: current status and future needs, Comput. Toxicol., 20, 10.1016/j.comtox.2021.100191 Xu, 2012, In silico prediction of chemical Ames mutagenicity, J. Chem. Inf. Model, 52, 2840, 10.1021/ci300400a Thresher, 2019, Generation of TD(50) values for carcinogenicity study data., Toxicol. Res., 8, 696, 10.1039/c9tx00118b Stampfer, 2019, Why maximum tolerated dose?, Br. J. Clin. Pharmacol., 85, 2213, 10.1111/bcp.14032 Lane, 2023, Comparing LD(50)/LC(50) machine learning models for multiple species, J. Chem. Health Saf., 30, 83, 10.1021/acs.chas.2c00088 Gadaleta, 2021, Integrated in silico models for the prediction of no-observed-(adverse)-effect levels and lowest-observed-(adverse)-effect levels in rats for sub-chronic repeated-dose toxicity, Chem. Res. Toxicol., 34, 247, 10.1021/acs.chemrestox.0c00176 Napiórkowska, 2023, Review of applications of density functional theory (DFT) quantum mechanical calculations to study the high-pressure polymorphs of organic crystalline materials, Int. J. Mol. Sci., 24, 10.3390/ijms241814155 Mazurek, 2020, Periodic DFT calculations-review of applications in the pharmaceutical sciences, Pharmaceutics, 12, 10.3390/pharmaceutics12050415 Frisch, M. , F.J.S. Clemente, V. Barone, B. Mennucci, G.A. Petersson, H. Nakatsuji, M. Caricato, X. Li, H.P. Hratchian, A.F. Izmaylov, J. Bloino, G. Zhe, Gaussian 09, revision a. 01, mj frisch, gw trucks, hb schlegel, ge scuseria, ma robb, jr cheeseman, g. 2009, 20–44. Altowyan, M.S., et al., Synthesis, X-ray, Hirshfeld, and AIM Studies on Zn (II) and Cd (II) Complexes with Pyridine Ligands. 2022. 12(5), 590. Wang, T., D.Z.J.E.S. Husein, P. Research, Novel Synthesis of Multicomponent Porous Nano-hybrid Composite, Theoretical Investigation Using DFT and Dye Adsorption Applications: Disposing of Waste with Waste. 2022, 1–28. Parmar, 2021, Discovery of new anticancer thiourea-azetidine hybrids: Design, synthesis, in vitro antiproliferative, SAR, in silico molecular docking against VEGFR-2, ADMET, toxicity, and DFT studies, Bioorg. Chem., 115, 10.1016/j.bioorg.2021.105206 Liu, X., et al., Molecular Dynamics Simulations and Novel Drug Discovery. 2018. 13(1), 23–37. De Vivo, 2016, Role of molecular dynamics and related methods in drug discovery, 59, 4035 Genheden, 2015, The MM/PBSA and MM/GBSA methods to estimate ligand-binding affinities, Expert Opin. Drug Discov., 10, 449, 10.1517/17460441.2015.1032936 Salentin, S., et al., From malaria to Cancer: Computational Drug Repositioning of Amodiaquine Using PLIP Interaction Patterns, 2017. 7(1), 11401. Tubiana, T., et al., TTClust: a Versatile Molecular Simulation Trajectory Clustering Program with Graphical Summaries, 2018. 58(11),. 2178–2182. Desdouits, N., et al., Principal component analysis reveals correlation of cavities evolution and functional motions in proteins, 2015. 55, 13–24. Daidone, I. , A.J.W.I.R.C.M.S. Amadei, Essential dynamics: foundation and applications, 2012. 2(5): p. 762–770. David, C.C., D.J.J.Pd.M. Jacobs, and Protocols, Principal Component Analysis: A Method for Determining the Essential Dynamics of Proteins, 2014, 193–226. Suleimen, 2022, Isolation and In Silico Inhibitory Potential against SARS-CoV-2 RNA Polymerase of the Rare Kaempferol 3-O-(6 ″-O-acetyl)-Glucoside from Calligonum tetrapterum, Plants, 11, 2072, 10.3390/plants11152072 Modi, 2019, Vascular endothelial growth factor receptor (VEGFR-2)/KDR inhibitors: medicinal chemistry perspective, Med. Drug Discov., 2, 10.1016/j.medidd.2019.100009 Jonkman, J.E., et al., An Introduction to the Wound Healing Assay Using Live-cell Microscopy, 2014. 8(5), 440–451.